Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JPPP: Aspirin for Primary Prevention in Elderly Japanese
NCT00225849Phase 4Unknown
- Sponsor
- Ministry of Health, Labour and Welfare
- Start
- Mar 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin in cardiovascular diseases (CVD) (2 arms), sponsored by Ministry of Health, Labour and Welfare. Primary endpoint: Composite event of cardiovascular death, nonfatal stroke, and nonfatal myocardial infarction. Status: unknown.
02
Drugs
aspirin
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT00225849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225849.